Side effects of idelalisib in CLL and how to manage them

Side effects of idelalisib in CLL and how to manage them

VJHemOnc

3 years
546 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jennifer Brown, MD, PhD from the Dana-Farber Cancer Institute, Boston, MA outlines the side effects that may occur in chronic lymphocytic leukemia (CLL) patients treated with idealisib and how to manage them. Side effects to look out for include neutropenia, bacterial infections, immunologic toxicitiy and diarrhea colitis. Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.
Up Next Autoplay
Personalized Algorithms: How is this different?
Personalized Algorithms: How is this different?
Category: Immunotherapy
2 Views
Cancer-News 17 hours
Algorithm Personalizing Best Targets for Immunotherapy
Algorithm Personalizing Best Targets for Immunotherapy
Category: Immunotherapy
1 Views
Cancer-News 17 hours
Algorithm personalizes the best targets for immunotherapy for cancer mutations.
Algorithm personalizes the best targets for immunotherapy for cancer mutations.
Category: Immunotherapy
4 Views
Cancer-News 17 hours
Analysis of Patients with Prior Gastrectomy Treated with LONSURF® (trifluridine and tipiracil) Published in JAMA Oncology
Analysis of Patients with Prior Gastrectomy Treated with LONSURF® (trifluridine and tipiracil) Published in JAMA Oncology
Category: Pancreatic Cancer
3 Views
Cancer-News 19 hours
Phase 2 PLEIADES Study: How This Affects Clinicians?
Phase 2 PLEIADES Study: How This Affects Clinicians?
Category: Multiple Myeloma
0 Views
Mount Sinai Health System 20 hours
PLEIADES Study: How Long Are Patients in Clinic?
PLEIADES Study: How Long Are Patients in Clinic?
Category: Multiple Myeloma
0 Views
Mount Sinai Health System 20 hours
Phase 2 PLEIADES Study
Phase 2 PLEIADES Study
Category: Multiple Myeloma
0 Views
Mount Sinai Health System 20 hours
BEACON Trial: What's Next?
BEACON Trial: What's Next?
Category: Colorectal Cancer
2 Views
Cancer-News 1 day
Phase 3 BEACON CRC Trial
Phase 3 BEACON CRC Trial
Category: Colorectal Cancer
3 Views
Cancer-News 1 day
EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
Category: Bladder Cancer
9 Views
Cancer-News 1 day